Medtronic suffered a regulatory and competitive setback Wednesday after a U.S. Food and Drug Administration advisory panel expressed concerns about Symplicity Spyral, a device to treat hypertension.

FDA issued a Class I recall for Medtronic's Left Heart Vent Catheters due to safety concerns. 3 injuries reported.

Medtronic disclosed Diabetes unit executive pay packages for 2025 and compensation targets for when they'll lead MiniMed as a ...

Five years after Medtronic's billion-dollar purchase of HeartWare International, the company discontinued the device at the center of acquisition — a miniaturized, implantable heart pump — with no ...

David Dinsmoor, the local Medtronic engineer who worked on Inceptiv Medtronic researchers say a recently approved closed-loop spinal cord stimulator marks one of the company’s biggest breakthroughs in ...

Medtronic plc on Thursday announced that it has stopped selling a heart failure device due to greater risks of strokes and deaths in comparison to other products on the market. Known as the Heartware ...

More and more medical studies show that heart issues in women are not only underdiagnosed but should be treated differently. A study Medtronic designed to test its Evolut TAVR (transcatheter aortic ...

(Reuters) - Medical technology company Medtronic PLC has asked a U.S. judge in California to dismiss as "threadbare" an antitrust lawsuit from rival device manufacturer Applied Medical Resources Corp ...

1. Medtronic wins 1st FDA approval for conduction system pacing The FDA awarded Medtronic the first and only approval for a conduction system pacing device with an extended label Oct. 17. The ...

Medtronic is a healthcare behemoth, developing and manufacturing medical devices for chronic diseases, with a broad and dominant portfolio of industry-leading products. The company has increased its ...

We recap the year's biggest executive hirings, promotions and departures at Medtronic, J&J MedTech, Intuitive and other ...